AR signaling in humanmalignancies: Prostate cancer and beyond

Keyphrases

• Prostate Cancer 100%
• Androgen Signaling 100%
• Androgen Receptor 60%
• Androgens 40%
• Disease Progression 20%
• Breast Cancer 20%
• Malignancy 20%
• Oncogenesis 20%
• Potential Treatments 20%
• Castration-resistant Prostate Cancer 20%
• Antiandrogen 20%
• Targeted Therapy 20%
• Angiogenesis 20%
• Bladder Cancer 20%
• Hepatocellular Carcinoma 20%
• Epigenetic Regulation 20%
• Wnt Signaling 20%
• Advanced Prostate Cancer 20%
• Transcriptional Regulation 20%
• Resistance Mechanisms 20%
• Receptor Targets 20%
• Signaling Regulation 20%
• Anti-androgen Therapy 20%
• Treatment Implications 20%
• Human Malignancies 20%
• Cancer Bladder 20%
• Salivary Gland Cancer 20%
• PI3 Kinase Signaling 20%
• Epithelial Malignancies 20%
• Cellular Pathways 20%

Medicine and Dentistry

• Prostate Cancer 100%
• Androgen Receptor 100%
• Cancer 37%
• Androgen 25%
• Malignant Neoplasm 12%
• Breast Cancer 12%
• Disease Exacerbation 12%
• Carcinogenesis 12%
• Bladder Cancer 12%
• Hepatocellular Carcinoma 12%
• Castration Resistant Prostate Cancer 12%
• Antiandrogen 12%
• Phosphoinositide 3-Kinase 12%
• Kinase Signaling 12%
• Angiogenesis 12%
• Antiandrogen Therapy 12%
• Salivary Gland Cancer 12%
• Wnt Signaling 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Prostate Cancer 100%
• Androgen Receptor 100%
• Antiandrogen 25%
• Androgen 25%
• Malignant Neoplasm 12%
• Disease Exacerbation 12%
• Breast Cancer 12%
• Castration Resistant Prostate Cancer 12%
• Liver Cell Carcinoma 12%
• Bladder Cancer 12%
• Phosphatidylinositol 3 Kinase 12%
• Salivary Gland Cancer 12%
• Wnt Protein 12%
• Carcinogenesis 12%